Home> Products> dopaminergic activity

{ "products": [ { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2024-06-27T07:33:46.566Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be4714cb45413344ec323", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 0.5 ", "description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "aids", "life", "food", "Order", "water", "brain", "EMAIL", "0.25mg", "nausea", "action", "bedtime", "disease", "tremors", "patients", "Benefits", "stiffness", "condition", "Parkinson", "Ropinirole", "likelihood", "medication", "information", "Introduction", "initial dose", "independence", "greater ease", "tolerability", "Key Features", "sterispharma", "bradykinesia", "sterisonline", "CALL/WHATSAPP", "sleep quality", "starting dose", "patient safety", "motor symptoms", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "dopamine agonist", "patient response", "daily activities", "symptom severity", "clinical response", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "Continued Monitoring", "healthcare providers", "therapeutic efficacy", "0.5mg dosage strength", "dopaminergic activity", "Ropinprime 0.5 therapy", "overall motor function", "potential side effects", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "flexible dosing regimens", "Administration Instructions", "Restless Legs Syndrome Relief", "Swallow Ropinprime 0.5 tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1893, "imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:34:25.708Z", "updatedon": "2024-06-26T07:04:57.853Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "ropinprime 0.5 mg tablet 10", "ropinprime 0.5 mg tablet uses", "ropin 0.5 injection", "ropinirole warnings", "ropinirole side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb194933ec7924333073c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PYRITIGMIN RIVA 1.5", "description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.", "price": 192.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2176, "imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:36:04.37Z", "updatedon": "2025-09-08T10:36:04.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rivastigmine 1.5 mg capsule", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 200", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 185.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2025-09-08T10:03:20.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefpodoxime Proxetil Tablets IP 200 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02a01f5434d48fca8b8e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BETHNEVOID 50", "description": "BETHNEVOID 50 contains Bethanechol Chloride 50 mg, a cholinergic agonist (parasympathomimetic) that helps stimulate bladder muscle contractions. By directly activating muscarinic receptors in the bladder, it improves urinary flow and assists patients struggling with urinary retention. This makes it especially useful for individuals experiencing difficulty in passing urine due to conditions like post-surgical recovery, postpartum complications, or certain bladder dysfunctions.\n\nThe action of Bethanechol enhances bladder tone, ensuring more effective emptying of urine and reducing the discomfort associated with incomplete bladder evacuation.\n\nUses of BETHNEVOID 50\n\nUrinary Retention Management – Assists patients who are unable to empty their bladder properly.\n\nPost-Surgical Retention – Restores smooth urination after procedures or anesthesia.\n\nNeurogenic Bladder Disorders – Beneficial for those with weak bladder muscles caused by nerve dysfunction.\n\nEnhanced Bladder Emptying – Reduces urinary stasis and lowers the risk of urinary tract infections (UTIs).\n\nSide Effects of BETHNEVOID 50\n\nLike all medicines, BETHNEVOID 50 may cause certain side effects, ranging from mild to less common but serious reactions.\n\nCommon Side Effects:\n\nAbdominal discomfort or cramps\n\nNausea and vomiting\n\nLoose stools (diarrhea)\n\nExcess salivation or sweating\n\nHeadache\n\nLess Common but Serious Side Effects:\n\nLow blood pressure (hypotension)\n\nDizziness or flushing\n\nBreathing difficulties (especially in asthma patients)\n\nIrregular or fast heartbeat\n\nUrinary urgency or overactivity\n\nSeek immediate medical attention if severe symptoms occur.\n\nPrecautions Before Taking BETHNEVOID 50\n\nNot for Obstructive Conditions – Should not be used if urinary obstruction or bladder stones are present.\n\nAsthma or COPD Patients – May aggravate respiratory issues.\n\nCardiac Concerns – Use with caution in individuals with heart disease, peptic ulcers, or low blood pressure.\n\nPregnancy & Breastfeeding – Only under medical advice.\n\nDriving & Alertness – May cause dizziness; avoid driving until the effect is known.\n\nDrug Interactions with BETHNEVOID 50\n\nOther Cholinergic Drugs – May intensify cholinergic side effects.\n\nAnticholinergics (e.g., Atropine, Hyoscyamine) – Can reduce Bethanechol’s effectiveness.\n\nBlood Pressure Medications – Risk of further lowering blood pressure.\n\nBronchoconstrictors – Can worsen respiratory problems if taken together.\n\nConclusion\n\nBETHNEVOID 50 (Bethanechol Chloride 50 mg Tablets) is an effective treatment for urinary retention and bladder dysfunction. By improving bladder muscle contractions, it ensures smoother urination, reduces infection risks, and enhances overall quality of life.\n\nWhen used under proper medical guidance, BETHNEVOID 50 is a reliable choice for patients recovering from surgery or dealing with neurogenic bladder conditions.", "price": 225.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2168, "imageuri": "https://productimages.withfloats.com/actual/68b02a049f24dedaddb226a2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b02a049f24dedaddb226a2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T10:05:53.188Z", "updatedon": "2025-08-28T10:22:32.936Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/bethnevoid-50/2168", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bethanechol Chloride 50 mg", "category": "UROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b0285a8456f6cd1a658352", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 5/10", "description": "ALFUGEM T 5/10 is a uniquely formulated combination of Alfuzosin Hydrochloride ER and Tadalafil, created to manage two common male health concerns—benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). This dual-benefit tablet not only helps relieve urinary symptoms caused by an enlarged prostate but also enhances sexual performance by improving blood flow to penile tissues.\n\nAlfuzosin, an alpha-1 adrenergic blocker, works by relaxing the smooth muscles of the prostate and bladder neck, allowing for easier urine flow. On the other hand, Tadalafil, a PDE5 inhibitor, relaxes blood vessels and supports better erections during sexual activity. Together, they offer a holistic treatment option for men dealing with both prostate-related urinary difficulties and sexual health concerns.\n\nUses of ALFUGEM T 5/10\n\nBenign Prostatic Hyperplasia (BPH): Eases urinary issues such as weak stream, frequent urination, incomplete bladder emptying, and difficulty initiating urination.\n\nErectile Dysfunction (ED): Improves erectile quality and sexual satisfaction.\n\nDual Therapy: Provides relief for men suffering from both BPH and ED, minimizing the need for multiple medications.\n\nEnhanced Quality of Life: Restores comfort, confidence, and overall wellness by improving both urinary and sexual functions.\n\nSide Effects of ALFUGEM T 5/10\n\nLike most medications, ALFUGEM T 5/10 may cause side effects, usually mild and temporary as the body adapts to treatment.\n\nCommon side effects include:\n\nHeadache\n\nDizziness or lightheadedness\n\nNasal congestion\n\nBack pain\n\nFlushing\n\nLess common but serious side effects:\n\nSudden low blood pressure (hypotension)\n\nSevere dizziness or fainting\n\nProlonged, painful erections (priapism – requires urgent care)\n\nVision or hearing disturbances\n\nAllergic reactions (rash, itching, facial/lip/throat swelling)\n\nPrecautions Before Use\n\nHeart Problems: Patients with recent heart attack, stroke, or serious heart disease should only use under strict medical advice.\n\nBlood Pressure: May lower blood pressure—avoid combining with other strong antihypertensives unless prescribed.\n\nNitrate Warning: Must not be used with nitrate medications (for chest pain/angina) due to risk of severe hypotension.\n\nLiver or Kidney Impairment: Dose adjustments may be needed.\n\nAlertness: Can cause dizziness—avoid driving or operating heavy machinery until you know your body’s response.\n\nDrug Interactions\n\nALFUGEM T 5/10 may interact with other medicines:\n\nNitrates (Nitroglycerin, Isosorbide): Can lead to life-threatening hypotension.\n\nAntihypertensives: May intensify blood pressure-lowering effects.\n\nOther PDE5 inhibitors (Sildenafil, Vardenafil): Should not be combined.\n\nStrong CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir): May increase Alfuzosin or Tadalafil levels.\n\nAlcohol: Increases dizziness and risk of low blood pressure.\n\nConclusion\n\nALFUGEM T 5/10 (Alfuzosin Hydrochloride ER & Tadalafil Tablets) is a comprehensive dual-action therapy designed for men experiencing both urinary issues due to BPH and sexual challenges related to ED. By combining an effective alpha-blocker with a proven PDE5 inhibitor, it provides relief from urinary discomfort while restoring erectile performance and confidence.\n\nWith proper medical guidance, ALFUGEM T 5/10 can greatly improve overall quality of life, making it a reliable option for men seeking urological and sexual wellness in a single solution.", "price": 385.0, "discountamount": 115.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2167, "imageuri": "https://productimages.withfloats.com/actual/68b0285da77b30c98906ef23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b0285da77b30c98906ef23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:58:50.008Z", "updatedon": "2025-08-28T09:58:50.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-5-10/2167", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Alfuzosin Hydrochloride ER & Tadalafil Tablets", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }